Ethnic differences in the neuroleptic treatment of schizophrenia

Pedro Ruiz, Roy V. Varner, David R. Small, Bankole A. Johnson

Research output: Contribution to journalArticle

30 Scopus citations

Abstract

Ethnic differences in psychopharmacological treatment have received much attention in the last two decades. Most of the research efforts conducted so far in the field of ethnopsychopharmacology have focused on comparative responses to neuroleptics and lithium between white and Asian-American patients, and on comparative responses to tricyclic antidepressants among white, African-American and Hispanic patients. In this article we focus on the response to neuroleptic treatment among white, African-American and Hispanic patients suffering from schizophrenia. Our findings suggest that Hispanic patients need lower doses of neuroleptics than white or African- American patients to attain a similar response in the treatment of schizophrenia. Additionally, our study suggests that, if weight is taken to consideration, African-American patients need the same dose of neuroleptics as do white patients in order to attain a similar response in the treatment of schizophrenia. Further studies are suggested to confirm our findings.

Original languageEnglish (US)
Pages (from-to)163-172
Number of pages10
JournalPsychiatric Quarterly
Volume70
Issue number2
DOIs
StatePublished - Jun 30 1999

ASJC Scopus subject areas

  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Ethnic differences in the neuroleptic treatment of schizophrenia'. Together they form a unique fingerprint.

  • Cite this

    Ruiz, P., Varner, R. V., Small, D. R., & Johnson, B. A. (1999). Ethnic differences in the neuroleptic treatment of schizophrenia. Psychiatric Quarterly, 70(2), 163-172. https://doi.org/10.1023/A:1022153403924